BAY 59-7939
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY 59-7939, covering 2014-10-28 to 2014-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement [Phase 2]